Clinical Trial

Quality of Life in Hereditary and Inflammatory Peripheral Neuropathies

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 14, 2026 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Neuromuscular diseases affect the nerves and muscles and can cause weakness, pain, fatigue, and difficulties in daily life. These problems may reduce independence, social participation, and overall quality of life.This observational study aims to evaluate the impact of peripheral neuropathies on quality of life. It focuses on two types of peripheral neuropathies: hereditary neuropathies, caused by genetic factors, and inflammatory neuropathies, caused by immune-related nerve damage. Adult patients with these conditions will be assessed at a single time point, without any change to their usual medical care. Participants will complete questionnaires about daily functioning, well-being, and quality of life. Some questions will also explore the use of assistive devices and supportive tools in everyday life.The study hypothesizes that peripheral neuropathies significantly affect quality of life and that this impact differs between hereditary and inflammatory forms. The results aim to improve understanding of patients' needs and support better, more personalized care."
Trial Details
NCT Number NCT07340749
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Hereditary and Inflammatory Peripheral Neuropathies
Enrollment 60 participants
Start Date 2026-02-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-14